FDA Drug Application (021366) for CRESTOR by IPR

Back to FDA Applications sponsored by IPR

Application Number021366
Product Number002
FormTABLET;ORAL
Dosage5MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameCRESTOR
Active IngredientROSUVASTATIN CALCIUM



Back to FDA Applications sponsored by IPR

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.